Neochem Bio Solutions Releases Audited Financial Results for FY 2026, Reporting 32% Jump in Revenue

Neochem Bio Solutions Releases Audited Financial Results for FY 2026, Reporting 32% Jump in Revenue

Neochem Bio Solutions Releases Audited Financial Results for FY 2026, Reporting 32% Jump in Revenue​

Neochem Bio Solutions Limited today announced its audited financial results for the half year and the full financial year ended March 31, 2026. The Board of Directors approved the results, confirming the figures with an unmodified opinion from the Statutory Auditors.

The financial performance highlights indicate significant growth across core metrics. The company reported a substantial increase in Revenue from Operations and Profit After Tax (PAT) year over year.

Financial Highlights (₹ Lakhs)​

The audited results show the following key metrics comparing the fiscal years 2024-25 and 2025-26:

MetricFY 2025-26FY 2024-25Year over Year Change
Revenue from Operations11,0698,417+ 32%
EBITDA2,1931,478+48%
PAT1,203744+62%
EPS (Rs. Per Share)8.71*11.15-

The company’s Balance Sheet summary reveals total equity and liabilities stood at 11,711.52 ₹ Lakhs as of March 31, 2026, compared to 7,889.13 ₹ Lakhs in the previous year. Total assets also reported a rise to 11,711.52 ₹ Lakhs.

Cash Flow Analysis​

The cash flow statement provides a detailed view of the company’s operational cash generation. For the year ended March 31, 2026, net cash generated from operating activities was (1,906.25) ₹ Lakhs, while the cash generated from financing activities was a positive 2,572.94 ₹ Lakhs. The net increase in cash and cash equivalents for the period was 12.61 ₹ Lakhs.

Audit Confirmation​

The Statutory Auditors, Patel Mehta & Associates, issued an Audit Report confirming an unmodified opinion on the financial statements.

Additionally, the auditors confirmed that the company has an adequate internal financial controls system over financial reporting, and that these controls were operating effectively as of March 31, 2026.

The results were reviewed and approved by the Audit Committee and the Board of Directors at their meeting on May 18, 2026.

NEOCHEM Stock Price Movement​

Neochem Bio Solutions Limited shares today tumbled by 3.85%, settling at ₹89.60 in post-market trading. The stock traded on a total volume of 39,600 shares today.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top